33480193 Kim D, Kim JM, Cho YW, Yang KI, Kim DW, Lee ST, No YJ, Seo JG, Byun JI, Kang KW, Kim KT
Bruising and swelling at injection sites affect up to 30% of patients starting tirzepatide therapy, though most cases are mild and resolve within days
IGF-1 LR3 Synonyms / Designations: IGF-1 LR3, Long Arg IGF-1, Insulin-Like Growth Factor-1 LR3, Recombinant IGF-1 analogue CAS Number: 946870-92-4 Molecular Formula: C400H625N111O115S9 Molecular Weight: 9117.5 g/mol Peptide Classification: Synthetic analogue of insulin-like growth factor-1 (IGF-1) Purity: 99 % (HPLC, typical) Appearance: White to off-white lyophilised powder Pack Size: 1 mg (total) Storage: Desiccated, protected from light, stored at 20 C Solubility: Soluble in sterile water and buffered aqueous solutions Description & Mechanism IGF-1 LR3 is a synthetic analogue of human insulin-like growth factor-1 (IGF-1) incorporating an arginine substitution at position 3 and an extended N-terminal sequence
Similar to CJC-1295, the combination of CJC-1295 + Ipamorelin stimulates growth hormone release, helping with muscle growth, fat reduction, and improved sleep
It is clinically approved for type 2 diabetes management